Is ANIP Undervalued? How to Read Its 9.3x Forward P/E

ANI Pharmaceuticals ANIP has shifted into a specialty-led growth story, with Cortrophin Gel now the main engine and the retina franchise positioned for a reset and recovery. At the same time, the stock's valuation has compressed to levels that stand out against peers and the broader market.
Open original source